Long-term tezacaftor/ivacaftor safety and efficacy in people with cystic fibrosis and an F508del-CFTR mutation: 96-week, open-label extension of the EXTEND trial
| Autor: | Flume, Patrick A., Harris, R. Scott, Paz-Diaz, Hildegarde, Ahluwalia, Neil, Higgins, Mark, Campbell, Daniel, Berhane, Indrias, Shih, Judy L., Sawicki, Gregory |
|---|---|
| Zdroj: | In Journal of Cystic Fibrosis May 2023 22(3):464-470 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect